Wright Medical gets Japanese nod for hip resurfacing system:
This article was originally published in Clinica
Executive Summary
Wright Medical has received regulatory approval from Japan's Ministry of Health, Labour and Welfare for its Conserve Plus hip resurfacing system. Hip resurfacing is a less invasive, bone sparing approach to hip surgery. The system is particularly aimed at younger, active patients suffering from chronic hip pain, and is designed to help patients achieve a greater range of motion and more natural gait, the Arlington, Tennessee company said. The Conserve plus system is currently available in Europe, Canada and Australia, among other markets. The product is yet to reach the US; Wright's premarket approval submission is still under FDA review.